Communicators

are winners!

Top News

22.01.2025
Halifax, Nova Scotia, 21st of January, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin clinical trials for new label claim applications of its recently Health Canada approved Multiplo® TP/HIV rapid test. These applications include use as a self-test and for non-professional administration, expanding access to testing for syphilis and HIV in Canada. More testing options are urgently needed amid soaring cases of syphilis and HIV in Canada, particularly in the Prairies. The upcoming trials for MedMira’s self and ... [ more ]